- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Gemtuzumab Ozogamicin
Total 796 results
-
Memorial Sloan Kettering Cancer CenterNational Institutes of Health (NIH)RecruitingHER2-positive Metastatic Breast Cancer | HER-2 Protein Overexpression | HER-2 Positive Malignant Carcinoma of BreastUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedHER2-positive Carcinoma | HER2-positive Primary MalignancyUnited States
-
PfizerUCB PharmaCompletedAcute Lymphocytic LeukemiaUnited States
-
Hoffmann-La RocheCompletedHER2-Positive Early Breast CancerUnited States, Finland, Hong Kong, Panama, Portugal, Spain, Mexico, Sweden, Brazil, Serbia, Argentina, Lebanon, Cuba, Qatar, Saudi Arabia, Chile, Jordan
-
National Cancer Institute (NCI)CompletedPeripheral T-Cell Lymphoma (PTCL) | T-Cell Prolymphocytic Leukemia | Cutaneous T Cell Lymphoma (CTCL) | T-Cell Lymphoma Relapsed | Adult T-Cell Leukemia (ATL)United States
-
Institut für Klinische Krebsforschung IKF GmbH...Trium Analysis Online GmbHCompletedStomach Cancer | Gastroesophageal Junction CancerGermany
-
Leeds Cancer Centre at St. James's University HospitalCompleted
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedLeukemiaUnited States, Israel
-
New York Medical CollegeTerminatedAcute Myeloid Leukemia | Juvenile Myelomonocytic Leukemia | Myelodysplastic SyndromeUnited States
-
Guangdong Provincial People's HospitalRecruitingNeoadjuvant Therapies for HER2+ Breast CancerChina
-
Grupo Cooperativo de Estudio y Tratamiento de las...CompletedNovo Acute Myeloid LeukemiaSpain
-
Fudan UniversityCompleted
-
Assistance Publique - Hôpitaux de ParisCompletedAcute Lymphocytic LeukemiaFrance
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)Completed
-
University of OxfordBoehringer Ingelheim; Prostate Cancer UKActive, not recruiting
-
Hospices Civils de LyonNot yet recruiting
-
Memorial Sloan Kettering Cancer CenterUnited States Department of Defense; Genentech, Inc.CompletedBreast Cancer Metastases | HER2 Positive BreastUnited States
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingA Trial of Eribulin in Combination With HP Neoadjuvant Therapy in Patients With for HER2-Positive BCHER2-positive Breast CancerChina
-
M.D. Anderson Cancer CenterWithdrawnLymphoma | Hodgkin's Disease
-
Genentech, Inc.Approved for marketing
-
Gilead SciencesCompleted
-
Fundacio Clinic BarcelonaRoche Pharma AG; SOLTI Breast Cancer Research GroupRecruitingStage I Breast Cancer | HER2-positive Breast CancerSpain
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)TerminatedChronic Lymphocytic LeukemiaUnited States
-
Tanta UniversityRecruitingParkinson DiseaseEgypt
-
Queen Mary University of LondonGilead SciencesUnknownRecurrent or Refractory B Cell Acute Lymphoblastic LeukaemiaUnited Kingdom
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruiting
-
Goethe UniversityCompletedLymphoma, Lymphoblastic | Adult Acute Lymphocytic Leukemia T-cellGermany
-
H. Lee Moffitt Cancer Center and Research InstituteWithdrawnBreast CancerUnited States
-
University of AlbertaJuvenile Diabetes Research FoundationCompleted
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruitingHER2-PositiveRecurrent or Metastatic Breast Cancer
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedRecurrent Acute Lymphoblastic Leukemia | Refractory Acute Lymphoblastic Leukemia | CD22 PositiveUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; TakedaNot yet recruiting
-
Gilead SciencesCompletedPrimary Sclerosing Cholangitis (PSC)United States, Belgium, Canada, Germany, United Kingdom, Italy, Spain, Denmark, Netherlands, Sweden
-
Genzyme, a Sanofi CompanyBayerCompletedMultiple Sclerosis, Relapsing-RemittingUnited States, Russian Federation, Poland, Croatia, United Kingdom
-
Emory UniversityTerminated
-
National Institute of Diabetes and Digestive and...CompletedEffectiveness of the Investigational Drug Campath-1H in Preventing Rejection of Transplanted KidneysGraft Rejection | Kidney DiseaseUnited States
-
Hospital Universitario Dr. Jose E. GonzalezCompletedIdiopathic Thrombocytopenic Purpura | Anemia, Hemolytic, AutoimmuneMexico
-
Sascha MüllerCompleted
-
Hoffmann-La RocheCompleted
-
Gilead SciencesCompletedNon-Hodgkin's LymphomaUnited States
-
Leland MethenyRecruitingAcute Lymphocytic LeukemiaUnited States
-
PfizerUCB PharmaTerminatedLymphoma, Non-HodgkinCanada, United States, Spain, France, Singapore, Taiwan, Japan, Ireland, Belgium, United Kingdom, Germany, Slovakia, Thailand, Croatia, Czechia, Russian Federation, India, Sweden, Poland, Bulgaria, Hungary, Lithuania, Mexico, Puerto Rico and more
-
Hospital Universitario Dr. Jose E. GonzalezCompletedGraft vs Host DiseaseMexico
-
University Hospital, Udine, ItalyCompleted
-
Genzyme, a Sanofi CompanyBayerCompletedMultiple Sclerosis, Relapsing-RemittingAustralia, Denmark, Canada, United States, Netherlands, Argentina, Austria, Belgium, Brazil, Croatia, Czech Republic, France, Germany, Israel, Italy, Mexico, Poland, Russian Federation, Serbia, Spain, Sweden, Ukraine, United Kingdom
-
University Hospital MuensterGenzyme, a Sanofi CompanyCompletedMultiple Sclerosis, Relapsing-RemittingGermany
-
Genentech, Inc.Completed
-
Mahidol UniversityBayerTerminatedPeripheral T-Cell LymphomaThailand
-
Phramongkutklao College of Medicine and HospitalBayerTerminated